18.52
0.11%
-0.02
Pharvaris Nv Aktie (PHVS) Neueste Nachrichten
Novo Holdings A S Has $32.43 Million Stock Position in Pharvaris (NASDAQ:PHVS) - MarketBeat
Pharvaris N.V.'s SWOT analysis: promising HAE drug boosts stock outlook - Investing.com UK
Pharvaris CBO Resigns, Team Absorbs Duties - TipRanks
(PHVS) Technical Data - Stock Traders Daily
Hereditary Angioedema Therapeutics Global Market Report Explores 2024: Size Forecast and Growth Prospects 2033 - WhaTech
Pharvaris (NASDAQ:PHVS) Shares Gap Down to $21.09 - MarketBeat
Jones Trading Initiates Coverage of Pharvaris N.V. (PHVS) with Buy Recommendation - MSN
Paradise, NV – Injuries Reported in Vehicle Accident on I-215 W near Las Vegas Blvd Onramp - Local Accident Reports
Las Vegas, NV – Accident on I-215 E near Windmill Ln Results in Injuries - Local Accident Reports
North Las Vegas Man Charged in Fatal Hit-and-Run After Allegedly Fleeing Accident Scene - Hoodline
Paradise, NV – Vehicle Accident at I-215 E and Las Vegas Blvd - Local Accident Reports
Las Vegas, NV – Vehicle Accident at CC215 S and W Sunset Rd Causes Injuries - Local Accident Reports
Highway reopens outside Las Vegas after crash, fire in semi hauling lithium batteries - KRNV
Highway reopens outside Las Vegas after crash, fire in semi hauling lithium batteries - FoxReno.com
Road closures persist after trucks carrying wood and batteries collide - News3LV
Appeal over identifying invasive hornets in Jersey - BBC.com
Hwy 95 closes in Nye County after crash involving truck carrying lithium batteries - Audacy
1 person transported to hospital after Henderson crash involving bicyclist - Fox 5 Las Vegas
1 hospitalized in Henderson crash involving bicyclistKLAS - KLAS - 8 News Now
Oregon man dies northwest of Las Vegas Valley, state police say - Fox 5 Las Vegas
1 person taken to hospital after crash involving car, bicyclist in Henderson - News3LV
Rep. Steven Horsford releases updated campaign ad after LVPPA concerns - KTNV 13 Action News Las Vegas
Silver Springs man killed in crash on U.S. 50A & 6th Street in Fernley - KTVN
Las Vegas, NV – Collision at CC215 S & W Flamingo Rd Results in Injuries - Local Accident Reports
Pharvaris (NASDAQ:PHVS) Shares Gap Up After Analyst Upgrade - MarketBeat
Pharvaris stock outlook strengthened with price target increase, Outperform rating reiterated by Oppenheimer - Investing.com UK
(PHVS) Technical Pivots with Risk Controls - Stock Traders Daily
Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and ... - The Bakersfield Californian
Pharvaris Provides Business Update and Expands Development Program for Deucrictibant - StockTitan
Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024 - StockTitan
Pharvaris Presents Data at the Bradykinin Symposium 2024 - StockTitan
Pharvaris to Present at SVB Securities Global Biopharma Conference - Yahoo Finance UK
Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium - Yahoo Finance UK
Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium - StockTitan
Pharvaris (NASDAQ:PHVS) Shares Gap Down to $19.08 - MarketBeat
Pharvaris (NASDAQ:PHVS) Stock Price Up 5.2% - MarketBeat
Pharvaris (NASDAQ:PHVS) Trading Down 2.4% - MarketBeat
(PHVS) Trading Advice - Stock Traders Daily
Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update - StockTitan
Pharvaris (NASDAQ:PHVS) Shares Up 5.1% - MarketBeat
Price T Rowe Associates Inc. MD Sells 84,783 Shares of Pharvaris (NASDAQ:PHVS) - Defense World
(PHVS) Investment Analysis and Advice - Stock Traders Daily
Viridian, Pharvaris said to be among prime M&A targets for Biogen - Seeking Alpha
Contrasting Avidity Biosciences (NASDAQ:RNA) and Pharvaris (NASDAQ:PHVS) - American Banking and Market News
Contrasting Avidity Biosciences (NASDAQ:RNA) and Pharvaris (NASDAQ:PHVS) - Defense World
Pharvaris (NASDAQ:PHVS) Price Target Raised to $38.00 at Oppenheimer - Defense World
Financial Analysis: Pharvaris (NASDAQ:PHVS) versus AC Immune (NASDAQ:ACIU) - Defense World
When the Price of (PHVS) Talks, People Listen - Stock Traders Daily
Pharvaris Announces Changes to its Board of Directors - Quantisnow
Pharvaris Shareholders Approve Key Resolutions - TipRanks
Pharvaris N.V.'s (NASDAQ:PHVS) largest shareholders are private equity firms with 44% ownership, institutions own 26% - Yahoo New Zealand News
(PHVS) Investment Analysis - Stock Traders Daily
Pharvaris NV [PHVS] stock Initiated by Wedbush analyst, price target now $27 – The DBT News - The DBT News
Pharvaris shares surge as treatment for severe swelling meets clinical trial goal - MSN
Blackstone Inc. Makes New $2.81 Million Investment in Pharvaris (NASDAQ:PHVS) - Defense World
Pharvaris Announces Annual Meeting of Shareholders - GlobeNewswire Inc.
Pharvaris Announces Annual Meeting of Shareholders | National | wdrb.com - WDRB
PHVSPharvaris N.V. Ordinary Shares Latest Stock News & Market Updates - StockTitan
Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses - WDRB
Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses - GlobeNewswire Inc.
Pharvaris (NASDAQ:PHVS) Shares Down 6.6% - Defense World
Pharvaris (PHVS) Up as FDA Lifts Clinical Hold on HAE Program - MSN
(PHVS) On The My Stocks Page - Stock Traders Daily
Morgan Stanley Reiterates Pharvaris (PHVS) Equal-Weight Recommendation - MSN
Objective long/short (PHVS) Report - Stock Traders Daily
Pharvaris (NASDAQ:PHVS) Price Target Lowered to $31.00 at Wedbush - Defense World
Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses - WDRB
Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses - GlobeNewswire Inc.
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):